Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

P. Rutkowski,Z. Nowecki,M. Debiec-Rychter,U. Grzesiakowska,W. Michej,A. Wozniak,J. Siedlecki,J. Limon,A. Dobosz,M. Kąkol,C. Osuch,W. Ruka
DOI: https://doi.org/10.1007/s00432-007-0202-4
2007-04-26
Journal of Cancer Research and Clinical Oncology
Abstract:
What problem does this paper attempt to address?